Edition:
India

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

1.06USD
2:29am IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.06
Open
$1.07
Day's High
$1.11
Day's Low
$0.90
Volume
230,947
Avg. Vol
42,977
52-wk High
$2.58
52-wk Low
$0.90

Latest Key Developments (Source: Significant Developments)

Second Sight Medical Products Implements Corporate Restructuring Plan
Thursday, 11 Oct 2018 

Oct 10 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT MEDICAL PRODUCTS SAYS ON OCT 9 CO IMPLEMENTED CORPORATE RESTRUCTURING PLAN.SECOND SIGHT MEDICAL - ANTICIPATES ANNUAL SAVINGS FROM RESTRUCTURING WILL AMOUNT TO ABOUT $3 MILLION PER YEAR.SECOND SIGHT SAYS WILL REDUCE EXPENSES, PERSONNEL BY 8 EMPLOYEES - SEC FILING.SECOND SIGHT - 8 EMPLOYEES ARE RELATED TO INTERNATIONAL COMMERCIAL OPERATIONS FOR ARGUS(REG) II RETINAL PROSTHESIS SYSTEM.  Full Article

SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION SYSTEM
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR THE ORION CORTICAL VISUAL PROSTHESIS SYSTEM.ORION ALLOWS PATIENTS MORE TIMELY ACCESS TO MEDICAL DEVICES BY EXPEDITING DEVELOPMENT, ASSESSMENT, REVIEW .FDA HAS GRANTED EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION CORTICAL VISUAL PROSTHESIS SYSTEM​.  Full Article

Second Sight Medical Products reports Q3 loss per share $0.12
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Second Sight Medical Products Inc :Second sight reports third quarter 2017 financial results.Q3 loss per share $0.12.Q3 sales $1.6 million versus $1.2 million.Second Sight Medical Products Inc - qtrly adjusted loss per share $0.11.  Full Article

Second Sight receives FDA approval to begin first Orion human clinical study
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Second Sight Medical Products Inc :Second Sight receives full FDA approval to begin first Orion human clinical study.Second sight-‍completed additional device testing, addressed remaining questions requested by FDA in prior conditional approval announced on Aug 28.Second Sight Medical Products Inc - ‍approval for Orion human clinical study allows two U.S. Sites to enroll up to five total patients​.  Full Article

Second Sight Medical Products files for mixed shelf of upto $100 mln‍​
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Second Sight Medical Products Inc :Second Sight Medical Products Inc files for mixed shelf of upto $100 million - sec filing‍​.  Full Article